Plasma-Adapted First-Line Pembro In NSCLC
Clinical trial NCT04166487 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04166487
- Sponsor
- Julia K. Rotow, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-13
- Primary completion
- 2025-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.